Peter R. Dolan

http://dbpedia.org/resource/Peter_R._Dolan an entity of type: Thing

Peter R. Dolan (born January 6, 1956) is an American business executive. In 2009, he became chairman and CEO of after joining the board in July 2008; he was formerly the chief executive officer of Bristol-Myers Squibb before being discharged from that company in September 2006 as a result of a federal investigation into questions concerning the patent of drug Plavix. rdf:langString
rdf:langString Peter R. Dolan
rdf:langString Peter R. Dolan
rdf:langString Peter R. Dolan
xsd:date 1956-01-06
xsd:integer 22370779
xsd:integer 1112382018
rdf:langString Tuck School of Business, 1980 (M.B.A.)
rdf:langString Tufts University, 1978 (B.A.)
xsd:date 1956-01-06
xsd:integer 2
rdf:langString American
rdf:langString Chief executive officer of Gemin X Pharmaceuticals
rdf:langString Lois Burkhart and John Ralph Dolan
rdf:langString Katherine Helen Lange
rdf:langString Peter R. Dolan (born January 6, 1956) is an American business executive. In 2009, he became chairman and CEO of after joining the board in July 2008; he was formerly the chief executive officer of Bristol-Myers Squibb before being discharged from that company in September 2006 as a result of a federal investigation into questions concerning the patent of drug Plavix.
xsd:nonNegativeInteger 9060
xsd:gYear 1956

data from the linked data cloud